Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 06 - 04    symbols : Amgn    save search

Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference
Published: 2021-06-04 (Crawled : 21:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

conference
Global $53 Bn Psoriasis Drugs Markets 2021-2030: Biologic Drugs, Small-Molecule Systemic Drugs, Topical Therapies, TNF-Alpha, PDE4, & Interleukin Inhibitors, Oral, Parenteral, Topical
Published: 2021-06-04 (Crawled : 21:00) - prnewswire.com
LLY | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BHC | $8.69 1.05% 0.0% 2.9M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
ABBV | News | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

drug psoriasis therapy
Results From Phase 2 CodeBreaK 100 Show LUMAKRAS™ (sotorasib) Is The First And Only KRAS G12C Inhibitor With Overall Survival Data
Published: 2021-06-04 (Crawled : 20:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BGNE | $129.51 -1.86% -1.89% 300K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

phase 2 results
New Drug Effective Against Lung Cancers Caused by Common Genetic Error
Published: 2021-06-04 (Crawled : 19:00) - prnewswire.com
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

new drug genetic lung cancer cancer drug
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.